GW Pharmaceuticals (GWPH) - Share Chat

GW Pharmaceuticals (Ticker GWPH) is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy was approved for treatment of epilepsy in 2018.

Absolutely got to agree with this, MMJ medical Marijuana is taking off! Now is a good time to invest …

1 Like

I’d love to invest most my money into this:)

1 Like

UK based CBD pharma. Please add!!

1 Like

Any news on this?

Bump too!

1 Like

Bump… :slight_smile: I just committed to this platform, because of the positive talks of cannabis stocks becoming available. I shall upvote on all the requests. GW pharma is a no brainier for UK company, in CBD and medical use.

Would love to see on the platform…

1 Like

And/or the Rize Medical Cannabis ETF?


What happened to this? It’s featured in the latest Freetrade email but I can’t find it on the app.

Are you looking on isa or basic? It should be in the basic

Ah I was in my ISA, thanks.

Wasn’t aware there were different stocks on basic vs ISA. Why is that?

In short, governmental regulations



HMRC regulations, to be exact.

HMRC have list of criteria what stocks can or cannot be in an ISA, and FT follows that same as any other broker.


Why has this cratered 20%? I can’t see any bad news in the results apart from one analyst claiming bad physician feedback.

Just got sold for $7.2bn

CBDX/CBDP LN has a 14% allocation to GWP. shot up 10% today

1 Like